More than 21,000 bottles of Viatros Inc. blood pressure medication have been recalled nationwide.
The Food and Drug Administration (FDA) announced a class III recall of Viatris Inc.'s combination telmisartan and amlodipine pill because it may contain more telmisartan than specified.
According to the notice, the recall was voluntarily initiated by Viatris on Oct. 1.
The FDA did not specify how much additional telmisartan is in the tablets. However, the National Library of Medicine warned that an overdosage of the specific medication could cause low blood pressure, dizziness or a rapid heart rate.
As a class III recall, the FDA has determined that use of the drug is not likely to cause health consequences.
What blood pressure medication was recalled?
In total, 21,620 bottles of the Viatris Inc.
medication were recalled.
The recall covers 30-count bottles of telmisartan and amlodipine tablets, 40 mg/5 mg, with the following lot codes:
- Lots 3228113, 3228114 and 3228115, with an expiration date of Oct. 31.
- Lots 3228120 and 3228121, with an expiration date of Nov. 30.
According to the FDA, those with the medication should not stop immediately taking it, as potential withdrawals may be more harmful.
Reach out to your doctor or pharmacist with questions or concerns.
Risha Inaganti writes about trending topics across South Jersey for the Courier-Post, Burlington County Times and Daily Journal. If you have a story she should tell, email her at rinaganti@usatodayco.com. Subscribe to stay up to date on the news you need.
This article originally appeared on Bucks County Courier Times: Blood pressure medication recalled due to potential excess drug level
